Exact Mass: 179.131

Methylephedrine

C11H17NO (179.131)

Methylephedrine belongs to the family of Amphetamines and Derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine.

Mexiletine

C11H17NO (179.131)

Mexiletine is only found in individuals that have used or taken this drug. It is an antiarrhythmic agent pharmacologically similar to lidocaine. It may have some anticonvulsant properties. [PubChem]Mexiletine, like lidocaine, inhibits the inward sodium current required for the initiation and conduction of impulses, thus reducing the rate of rise of the action potential, Phase 0. It achieves this reduced sodium current by inhibiting sodium channels. Mexiletine decreases the effective refractory period (ERP) in Purkinje fibers in the heart. The decrease in ERP is of lesser magnitude than the decrease in action potential duration (APD), which results in an increase in the ERP/APD ratio. It does not significantly affect resting membrane potential or sinus node automaticity, left ventricular function, systolic arterial blood pressure, atrioventricular (AV) conduction velocity, or QRS or QT intervals C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BB - Antiarrhythmics, class ib D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3010 D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

Tecomine

C11H17NO (179.131)

Methoxyphenamine

C11H17NO (179.131)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists Methoxyphenamine belongs to the family of Amphetamines and Derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine. C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

3-Ethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one

C11H17NO (179.131)

Proline-derived Maillard product. Proline-derived Maillard product

5-Ethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one

C11H17NO (179.131)

Proline-derived Maillard product. Proline-derived Maillard product

3,4-Dimethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one

C11H17NO (179.131)

Proline-derived Maillard product. Proline-derived Maillard product

7-Ethyl-2,3,4,5,6,7-hexahydrocyclopent[b]azepin-8(1H)-one

C11H17NO (179.131)

Proline-derived Maillard product. Proline-derived Maillard product

2,3,4,5,6,7-Hexahydro-6,7-dimethylcyclopent[b]azepin-8(1H)-one

C11H17NO (179.131)

Proline-specific Maillard product. Proline-specific Maillard product

trans-4,5-Dimethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one

C11H17NO (179.131)

Proline-derived Maillard product. Proline-derived Maillard product

4-Methylracephedrine

C11H17NO (179.131)

Ephedrine methyl ether

C11H17NO (179.131)

p-Methoxymethamphetamine

C11H17NO (179.131)

Methylpseudoephedrine

C11H17NO (179.131)

3-Methoxymethamphetamine

C11H17NO (179.131)

2-Ethylamino-1-phenylpropanol

C11H17NO (179.131)

p-Methoxymethamphetamine

C11H17NO (179.131)

2-(N-methylamino)-1-phenyl-1-butanol

C11H17NO (179.131)

4-(2-(Trimethylammonio)ethyl)phenolate

C11H17NO (179.131)

SCHEMBL4068305

C11H17NO (179.131)

SCHEMBL12102742

C11H17NO (179.131)

AKOS017657478

C11H17NO (179.131)

Descyclohexanol venlafaxine

C11H17NO (179.131)

N-Hydroxymephentermine

C11H17NO (179.131)

MEX_180.1383_11.9

C11H17NO (179.131)

CONFIDENCE Parent Substance with Reference Standard (Level 1); INTERNAL_ID 900

Mexiletine

C11H17NO (179.131)

C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BB - Antiarrhythmics, class ib D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

2-(N-Ethyl-m-toluidino)ethanol

C11H17NO (179.131)

CONFIDENCE standard compound; INTERNAL_ID 548; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5311; ORIGINAL_PRECURSOR_SCAN_NO 5309 CONFIDENCE standard compound; INTERNAL_ID 548; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5341; ORIGINAL_PRECURSOR_SCAN_NO 5339 CONFIDENCE standard compound; INTERNAL_ID 548; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5342; ORIGINAL_PRECURSOR_SCAN_NO 5340 CONFIDENCE standard compound; INTERNAL_ID 548; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5357; ORIGINAL_PRECURSOR_SCAN_NO 5356 CONFIDENCE standard compound; INTERNAL_ID 548; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5367; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 548; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5361; ORIGINAL_PRECURSOR_SCAN_NO 5360

N-Methylephedrine; AIF; CE0; CorrDec

C11H17NO (179.131)

N-Methylephedrine; AIF; CE10; CorrDec

C11H17NO (179.131)

N-Methylephedrine; AIF; CE30; CorrDec

C11H17NO (179.131)

N-Methylephedrine; AIF; CE0; MS2Dec

C11H17NO (179.131)

N-Methylephedrine; AIF; CE10; MS2Dec

C11H17NO (179.131)

N-Methylephedrine; AIF; CE30; MS2Dec

C11H17NO (179.131)

N-Methylephedrine; LC-tDDA; CE10

C11H17NO (179.131)

N-Methylephedrine; LC-tDDA; CE20

C11H17NO (179.131)

N-Methylephedrine; LC-tDDA; CE30

C11H17NO (179.131)

N-Methylephedrine; LC-tDDA; CE40

C11H17NO (179.131)

1-Phenyl-2-(ethylamino)-1-propanol

C11H17NO (179.131)

Edrophonium

C11H17NO (179.131)

CP 24,879

C11H17NO (179.131)

3-Ethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one

C11H17NO (179.131)

5-Ethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one

C11H17NO (179.131)

3,4-Dimethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one

C11H17NO (179.131)

7-ethyl-1H,2H,3H,4H,5H,6H,7H,8H-cyclopenta[b]azepin-8-one

C11H17NO (179.131)

2,3,4,5,6,7-Hexahydro-6,7-dimethylcyclopent[b]azepin-8(1H)-one

C11H17NO (179.131)

4,5-dimethyl-2-(pyrrolidin-1-yl)cyclopent-2-en-1-one

C11H17NO (179.131)

Ortoxine

C11H17NO (179.131)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

Phenol,2-amino-4-(1,1-dimethylpropyl)-

C11H17NO (179.131)

N-(2-AMINOETHYL)-N-PYRIMIDIN-2-YLAMINE

C11H17NO (179.131)

N-ethyl-2-(4-methylphenoxy)ethanamine

C11H17NO (179.131)

1-(4-Ethoxyphenyl)propan-1-amine

C11H17NO (179.131)

1-(3-Propoxyphenyl)ethanamine

C11H17NO (179.131)

Isopropyl (4-methoxybenzyl)-amine

C11H17NO (179.131)

(2R)-2-(Isopropylamino)-2-phenylethanol

C11H17NO (179.131)

(R)-(-)-2,2-DIMETHYL-5-OXO-1,3-DIOXOLANE-4-ACETICACID

C11H17NO (179.131)

4-[3-(dimethylamino)propyl]phenol

C11H17NO (179.131)

(alphaS)-3-Methoxy-N,N,alpha-trimethylbenzenemethanamine

C11H17NO (179.131)

N,N-Dimethyl-3-phenyl-3-hydroxypropylamine

C11H17NO (179.131)

2-CHLORO-4-PIVALAMIDONICOTINIC ACID

C11H17NO (179.131)

(S)-1-CHLORO-2-PROPANOL

C11H17NO (179.131)

(S)-(+)-2-AMINO-3-CYCLOHEXYL-1-PROPANOLHYDROCHLORIDE

C11H17NO (179.131)

Phenol,2-[(dimethylamino)methyl]-4,6-dimethyl-

C11H17NO (179.131)

2-[(dimethylamino)methyl]-4-ethylphenol

C11H17NO (179.131)

2-(4-Isopropyl-phenoxy)-ethylamine

C11H17NO (179.131)

1(p-methoxyphenyl)-3-butylamine

C11H17NO (179.131)

4-(2-METHYL-PROPYLAMINO)-3-METHYL-PHENOL

C11H17NO (179.131)

N-(1-adamantyl)formamide

C11H17NO (179.131)

1-(3-methoxyphenyl)-2-methylpropan-2-amine

C11H17NO (179.131)

4-Benzylamino-1-butanol

C11H17NO (179.131)

4-P-TOLYLAMINO-BUTAN-1-OL

C11H17NO (179.131)

1-Propanol,3-[methyl(phenylmethyl)amino]-

C11H17NO (179.131)

1-(3-Ethoxyphenyl)-N,N-dimethylmethanamine

C11H17NO (179.131)

3-(4-ethoxyphenyl)propan-1-amine(SALTDATA: FREE)

C11H17NO (179.131)

(4-(TERT-BUTOXY)PHENYL)METHANAMINE

C11H17NO (179.131)

(R)-(-)-2-HEXANOL

C11H17NO (179.131)

4-(4-Methoxyphenyl)butanamine

C11H17NO (179.131)

N-[2-(3,5-DIMETHYLPHENOXY)ETHYL]-N-METHYLAMINE

C11H17NO (179.131)

N,N-diethyl-m-anisidine

C11H17NO (179.131)

2-Amine-4-tert-butylanisole

C11H17NO (179.131)

2-(2,4,6-trimethylphenoxy)ethanamine

C11H17NO (179.131)

N-(2-Methoxybenzyl)-2-propanamine

C11H17NO (179.131)

N-(CYCLOPROPYLMETHYL)-2,5-DIMETHYLANILINE

C11H17NO (179.131)

alpha-(Isopropylaminomethyl)benzyl alcohol

C11H17NO (179.131)

ETHYL 5-AMINO-1-BENZYL-1H-IMIDAZOLE-4-CARBOXYLATE

C11H17NO (179.131)

[1-(4-ETHOXY-PHENYL)-ETHYL]-METHYL-AMINE

C11H17NO (179.131)

CYCLOHEXYL-FURAN-3-YLMETHYL-AMINO

C11H17NO (179.131)

2-(3-methoxyphenyl)-2-methylpropan-1-amine

C11H17NO (179.131)

N-(2-phenoxyethyl)propan-2-amine

C11H17NO (179.131)

2-(2-FURYLMETHYL)CYCLOHEXANAMINE

C11H17NO (179.131)

(r)-(-)-2-amino-1-benzyloxybutane

C11H17NO (179.131)

(4-butoxyphenyl)methanamine

C11H17NO (179.131)

1-Adamantanecarboxamide

C11H17NO (179.131)

CYCLOHEXYL-FURAN-2-YLMETHYL-AMINO

C11H17NO (179.131)

(4-METHYL-THIAZOL-2-YLSULFANYL)-ACETIC ACID

C11H17NO (179.131)

4-(3-methoxyphenyl)butan-1-amine

C11H17NO (179.131)

(S)-3-dimethylamino-3-phenylpropanol

C11H17NO (179.131)

1-(4-Isobutoxyphenyl)methanamine

C11H17NO (179.131)

(+)-N-METHYLEPHEDRINE

C11H17NO (179.131)

(S)-2-Phenyl-2-phenylamino-ethanol

C11H17NO (179.131)

1-(3-methoxy-4-methylphenyl)-2-aminopropane

C11H17NO (179.131)

(S)-4-(2-methyl-butoxy)-phenylamine

C11H17NO (179.131)

p-pentyloxyaniline

C11H17NO (179.131)

(4-(SEC-BUTOXY)PHENYL)METHANAMINE

C11H17NO (179.131)

1-(4-methoxyphenyl)-2-methylpropan-2-amine

C11H17NO (179.131)

Phenol, 4-[(dimethylamino)methyl]-2,6-dimethyl-

C11H17NO (179.131)

4-(3-Methylbutoxy)aniline

C11H17NO (179.131)

Methylephedrine

C11H17NO (179.131)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

(2R)-1-(2,6-dimethylphenoxy)propan-2-amine

C11H17NO (179.131)

4-Methylracephedrine

C11H17NO (179.131)

(+)-N-Methylpseudoephedrine

C11H17NO (179.131)

2-methoxyphenamine hcl

C11H17NO (179.131)

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

N-Methylephedrine

C11H17NO (179.131)

trans-4,5-Dimethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one

C11H17NO (179.131)

7-Ethyl-2,3,4,5,6,7-hexahydrocyclopent[b]azepin-8(1H)-one

C11H17NO (179.131)

n-methylpseudoephedrine

C11H17NO (179.131)

4-ethoxyamphetamine

C11H17NO (179.131)

(1r)-2-(dimethylamino)-1-phenylpropan-1-ol

C11H17NO (179.131)

(1r,2r)-2-(dimethylamino)-1-phenylpropan-1-ol

C11H17NO (179.131)

4-(2-methoxyethyl)-n,n-dimethylaniline

C11H17NO (179.131)

1-{9-azabicyclo[4.2.1]non-2-en-2-yl}propan-1-one

C11H17NO (179.131)

1-[(1r,6r)-9-azabicyclo[4.2.1]non-2-en-2-yl]propan-1-one

C11H17NO (179.131)